| Page 142 | Kisaco Research

Nutrition is emerging as a powerful tool for preventing disease and strengthening immunity in livestock. Changemakers leading this shift explore the opportunities and hurdles that will shape evidence generation, farmer adoption, and the scaling of preventative nutrition across global production systems.

  • Evidence generation – building the data to prove measurable impact on health and productivity
  • Scaling adoption – integrating precision nutrition into commercial production systems
Panellists

Author:

Aaron Schacht

CEO
BiomEdit

Aaron Schacht

CEO
BiomEdit

Author:

Philippe Tramoy

Partner
Seventure Partners

Philippe Tramoy

Partner
Seventure Partners

Monoclonal antibodies are redefining therapeutic possibilities in animal health, offering precise, targeted alternatives to traditional treatments. With next-generation innovation expanding into new disease areas and species, changemakers at the forefront examine the opportunities and hurdles that will shape development, approval, and adoption.

  • Regulatory pathways – navigating approval processes for novel biologics
  • Clinical adoption – driving veterinary education and confidence in new therapies
Panellists

Author:

Denise Bevers

President & CEO
VETmAb Biosciences, Inc

Denise Bevers

President & CEO
VETmAb Biosciences, Inc

Author:

Steve Nanchen

Senior Director, External Innovation EU & APAC Pacific
Elanco

Steve Nanchen

Senior Director, External Innovation EU & APAC Pacific
Elanco

Antimicrobial resistance is one of the most urgent challenges in animal and human health, demanding new approaches beyond traditional antibiotics. Changemakers developing preventative strategies and non-antibiotic alternatives explore the opportunities and hurdles that will define how these tools expand the veterinary toolkit, reduce dependence, and safeguard vital medicines.

  • Market positioning – differentiating alternatives from traditional antibiotics
  • Adoption drivers – proving cost-effectiveness and securing veterinary and farmer buy-in
Panellists

Author:

Tom Weaver

Co-Founder & Chairman
PetMedix & ArkVax

Tom Weaver

Co-Founder & Chairman
PetMedix & ArkVax

Rapid diagnostics are transforming everyday veterinary practice, enabling earlier detection and faster decision-making. Changemakers explore the latest advances in point-of-care tools, their role in improving outcomes, and the challenges of validation, adoption, and integration into workflows.

  • Validation – generating clinical evidence to support regulatory approval and vet adoption
  • Integration – embedding diagnostics into workflows for scale and commercial uptake
Moderator

Author:

Joe Harvey

Head of Animal Health
S&P Global

Joe Harvey

Head of Animal Health
S&P Global
Panellists

Author:

Richard Mellanby

Global Head of Medical Innovation and Strategy
IDEXX

Richard Mellanby

Global Head of Medical Innovation and Strategy
IDEXX

Veterinary associations recommend regular parasite control and diagnostics to prevent transmission. However, parasiticides face growing scrutiny over environmental and health concerns. With resistance increasing, changemakers are developing innovative solutions, ranging from new treatments to advanced diagnostics and targeted delivery, ensuring long-term protection for animals and humans.

  • Market differentiation – demonstrating value of novel products in a crowded market
  • Adoption hurdles – balancing efficacy, cost, and stewardship to drive uptake
Moderator

Author:

Claire Fowler

SVP Head of Global Strategic Marketing Animal Health,
Boehringer Ingelheim

After completing a degree in Veterinary Medicine at Cambridge University in 2002, her first professional experience was working in clinical veterinary practice before joining Boehringer Ingelheim in 2005. She subsequently completed an MBA at London Business School.

 

In Boehringer Ingelheim she has held positions at a local, regional and global level across business management, marketing and technical functions, mainly in Animal Health. This includes senior leadership roles such as the responsibility for the Boehringer Ingelheim Italian animal health subsidiary, and most recently for the overall commercial performance of the region encompassing Europe and Canada.  She also spent some time in Consumer Health Care as Category lead in global marketing.

 

Claire was appointed Head of Global Strategic Marketing in January 2025 and became a member of the Executive Committee of the Animal Health Business Unit at Boehringer.

Claire Fowler

SVP Head of Global Strategic Marketing Animal Health,
Boehringer Ingelheim

After completing a degree in Veterinary Medicine at Cambridge University in 2002, her first professional experience was working in clinical veterinary practice before joining Boehringer Ingelheim in 2005. She subsequently completed an MBA at London Business School.

 

In Boehringer Ingelheim she has held positions at a local, regional and global level across business management, marketing and technical functions, mainly in Animal Health. This includes senior leadership roles such as the responsibility for the Boehringer Ingelheim Italian animal health subsidiary, and most recently for the overall commercial performance of the region encompassing Europe and Canada.  She also spent some time in Consumer Health Care as Category lead in global marketing.

 

Claire was appointed Head of Global Strategic Marketing in January 2025 and became a member of the Executive Committee of the Animal Health Business Unit at Boehringer.

Advances in genetics and genomics are enabling faster progress in productivity, welfare, and disease resistance across livestock species. Changemakers highlight the changemakers applying genomic selection, gene editing, and advanced breeding strategies to improve animal health outcomes and productivity.

  • Regulatory pathways – navigating approval and acceptance of genomic technologies
  • Market adoption – demonstrating value to farmers and integrating innovation into breeding programs
Panellists

Author:

Dr Eve Hanks

Chief Executive Officer & Founder
MI:RNA Diagnostics

Dr Eve Hanks

Chief Executive Officer & Founder
MI:RNA Diagnostics

Author:

Owen Willems

Global Director R&D and Innovation
Hendrix Genetics

Owen Willems

Global Director R&D and Innovation
Hendrix Genetics

Nutrition-based therapies are redefining companion animal care, offering evidence-driven approaches to manage metabolic, inflammatory, and chronic conditions. With advances moving from research to practice, changemakers at the forefront of science and product development explore the opportunities and hurdles that will shape clinical validation, adoption, and long-term impact.

  • Clinical validation – generating evidence to secure veterinary confidence and consumer trust
  • Market adoption – positioning nutrition as a credible option to treat chronic disease
Moderator

Author:

Julie Lawless

President
Lawless Strategic Communications

Julie Lawless

President
Lawless Strategic Communications
Panellists

Author:

Rosa Carbonell

President
FEDIAF

Rosa Carbonell

President
FEDIAF

Author:

Courtney Miller

Chief Veterinary & Innovation Officer
Vetnique

Courtney Miller

Chief Veterinary & Innovation Officer
Vetnique

Cell and gene therapies are redefining the possibilities of veterinary medicine offering the potential to repair, replace, and restore biological function. With the first approvals expected as early as 2026, changemakers at the forefront of research and commercialisation explore the opportunities and hurdles that will define their path to clinical adoption.

  • Clinical adoption – building veterinary trust and integrating into practice workflows
  • Distribution – ensuring stability, scalability, and accessibility
Panellists

Author:

Linda Black

CEO
Gallant

Linda Black

CEO
Gallant

Author:

Thomas Koch

Founder, CEO & CSO
eQcell Inc

Thomas Koch

Founder, CEO & CSO
eQcell Inc

Author:

Julia Loew

Chief Commercial Officer
MWI Animal Health

Julia Loew

Chief Commercial Officer
MWI Animal Health

Artificial intelligence can play a vital role by enabling predictive analytics to help farmers anticipate productivity changes and prevent health issues before they escalate. Hear from the changemakers applying data-driven insights to deliver measurable health and productivity gains across livestock systems.

  • Demonstrating ROI – building the evidence base to drive farmer adoption
  • Data – overcoming the challenge of dispersed datasets from farms, labs and clinics
  • Route to market – integrating AI tools into existing farm management systems
Panellists

Author:

Paul Horwood

UK Head of Farm
IVC Evidensia

Paul Horwood

UK Head of Farm
IVC Evidensia

Author:

Robert Hyde

Co-Founder and CTO
Vet Vision AI

Robert Hyde

Co-Founder and CTO
Vet Vision AI

Author:

Arjun Ganesan

CEO
Ancera

Arjun Ganesan

CEO
Ancera